CD8A and colorectal carcinoma: In CRC patients, a good prognosis has been reported to be associated with the presence of CD3 + and CD8 + markers of the cytotoxic immune response.15–20,26 Consistent with previous reports, this study confirmed the usefulness of CD3 + and CD8 + T-cell densities as prognostic factors (Fig. 3a–d).